NEU1 and rheumatoid arthritis: When RA patients at Month 0 were classified by use of biologics, the difference in the B-cell Neu1 levels was significantly dissimilar between the ACR improvement group and the non-improvement group (Figure 4), the same as the results in Figure 1 and Figure 2, but different from those in Figure 3.